Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARQ-252 Cream in Chronic Hand Eczema
NCT04378569Phase 2Completed
- Sponsor
- Arcutis Biotherapeutics
- Start
- Apr 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of ivarmacitinib in chronic hand eczema (CHE), sponsored by Arcutis Biotherapeutics. Started Apr 2020; status: completed.
02
Drugs
ivarmacitinib
03
Conditions
chronic hand eczema (CHE)
Beyond the preview
Go deeper on NCT04378569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04378569.